Keywords: Almirall, AB-Biotics, equity stake, Personalized medicines, Research

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics

Article | 24 October 2012

Print This

Spain’s largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in